HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The introduction of 9,9-dioxopromethazine (Prothanon) into the treatment of skin diseases in hospitalized patients].

AuthorsH Nitzschner
JournalDie Pharmazie (Pharmazie) Vol. 25 Issue 2 Pg. 111-3 (Feb 02 1970) ISSN: 0031-7144 [Print] Germany
Vernacular TitleDer Einsatz von 9.9-Dioxopromethazin (Prothanon) bei stationär behandelten Hautkrankheiten.
PMID4393059 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Blood Glucose
  • Dermatologic Agents
  • Histamine H1 Antagonists
  • Placebos
  • Promethazine
Topics
  • Blood (drug effects)
  • Blood Glucose (analysis)
  • Clinical Trials as Topic
  • Dermatitis Herpetiformis (drug therapy)
  • Dermatologic Agents
  • Drug Hypersensitivity (drug therapy)
  • Eczema (drug therapy)
  • Electrophoresis
  • Fatigue (chemically induced)
  • Headache (chemically induced)
  • Histamine H1 Antagonists (therapeutic use)
  • Hospitalization
  • Humans
  • Placebos
  • Promethazine (administration & dosage, adverse effects, pharmacology, therapeutic use)
  • Pruritus (drug therapy)
  • Psoriasis (drug therapy)
  • Skin Diseases (drug therapy)
  • Urine (drug effects)
  • Urticaria (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: